Navigation Links
Vanderbilt study finds women referred for bladder cancer less often than men
Date:5/27/2014

Women with blood in their urine (hematuria) were less than half as likely as men with the same issue to be referred to a urologist for further tests, according to a new Vanderbilt University study.

The findings may help explain why women with bladder cancer are often diagnosed at a later stage in the disease and have worse mortality than men.

The study, presented by Jeffrey Bassett, M.D., MPH, fellow in Urologic Oncology, and Principal Investigator Daniel Barocas, M.D., MPH, assistant professor of Urologic Surgery, was shared during the American Urological Association (AUA) annual conference held May 16 - 21 in Orlando, Florida, and was highlighted during the AUA press program.

Blood in the urine is often the first sign of bladder cancer. The AUA recommends that everyone over 35 with hematuria not due to a benign cause receive an evaluation that includes looking inside the bladder (cystoscopy) as well as imaging of the urinary tract, usually with a CT scan.

For this study, investigators reviewed the medical records of a random sample of 9,211 Medicare beneficiaries diagnosed with hematuria between January 2009 and June 2010. Only 17 percent of females with a diagnosis of hematuria from their primary care provider were referred to a urologist for a diagnostic workup within 180 days, compared to 39 percent of men. Receipt of a complete evaluation did not differ by race.

"The data in the literature suggest that the misdiagnosis and treatment of hematuria in women as urinary tract infection is one of the main reasons they present with more advanced stage bladder cancer at diagnosis," said Bassett.

Some of the difference may be clinical decision-making by physicians who know that women are less likely to have bladder cancer than men. But Barocas said the disparities suggest primary care physicians may need to be more vigilant.

"We are missing opportunities to diagnose these cancers early enough and it's increasing the treatment burden and mortality for women. Because we see such advanced disease in women and they are worked up for hematuria so much less frequently, there may be a need to figure out how to risk-stratify women to know whether or not they need a workup," said Barocas.


'/>"/>
Contact: Craig Boerner
craig.boerner@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
Source:Eurekalert

Related medicine news :

1. Vanderbilt study finds obesity linked to kidney injury after heart surgery
2. Vanderbilt researchers find proteins may point way to new prostate cancer drug targets
3. Vanderbilt-led study reveals racial disparities in prostate cancer care
4. Vanderbilt study looks at benefits of progestogens to prevent early childbirth
5. UNC, Vanderbilt discover a new live vaccine approach for SARS and novel coronaviruses
6. Vanderbilt study finds diverse genetic alterations in triple-negative breast cancers
7. Vanderbilt study examines Affordable Care Acts impact on uncompensated care
8. Vanderbilt study reveals clues to childhood respiratory virus
9. Vanderbilt study finds maternal diet important predictor of severity for infant RSV
10. Vanderbilt study finds lack of exercise not a factor in health disparities
11. AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 03, 2016 , ... While James Earl Jones is known for myriad ... a show called "Front Page". One of the forthcoming episodes examines mammogram techniques; a ... plummeted in large part due to early detection. Like any other disease, treatments have ...
(Date:12/4/2016)... CA (PRWEB) , ... December 04, 2016 , ... ... without undergoing major cosmetic surgery can now take advantage of a cosmetic procedure ... advanced skin rejuvenation treatment that reduces the appearance of age spots, fine ...
(Date:12/2/2016)... ... 02, 2016 , ... Lori G. Cohen and Sara K. ... at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference , ... of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than 100 ... are expected to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. This ... area students and operating support to UNCF-member institutions, including Miles College, Oakwood University, ...
(Date:12/2/2016)... , ... December 02, 2016 , ... The annual time ... Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare beneficiaries who are ... or prescription drug plan (Part D) need to make changes during this period order ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2016 Research and Markets has announced the ... their offering. ... R&D Drug Pipeline Database: 1-Year ... Drug Pipeline Database provides 24/7 online access to information about more ... and on investigational drug candidates in research & development. ...
(Date:12/2/2016)... , December 2, 2016 bioLytical Laboratories, un líder mundial ... el INSTI HIV Self Test , a los miembros de la Kenya ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical fue ...
(Date:12/2/2016)...  LifeVac, the revolutionary device that has successfully rescued ... Training and Support Services (ERTSS) training programs. ... part of the ERTSS mission to save lives," said ... "Having an established network of expert trainers demonstrating how ... our efforts to spread LifeVac,s message that choking deaths ...
Breaking Medicine Technology: